home / stock / alzn / alzn short
Short Information | Alzamend Neuro Inc. (NASDAQ:ALZN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 394,847 |
Total Actual Volume | 2,027,454 |
Short Trends | |
---|---|
Cover Days | 15 |
Short Days | 1 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 19,742 |
Average Short Percentage | 29.26% |
Is there a ALZN Short Squeeze or Breakout about to happen?
See the ALZN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $0.403 | $0.3909 | $0.41 | $0.38 | 61,944 | 25,466 | 41.11% |
07-03-2024 | $0.3959 | $0.39 | $0.419899 | $0.3707 | 36,477 | 13,925 | 38.17% |
07-02-2024 | $0.4086 | $0.396 | $0.45 | $0.395 | 52,242 | 17,542 | 33.58% |
07-01-2024 | $0.391 | $0.4087 | $0.42 | $0.391 | 29,313 | 9,583 | 32.69% |
06-28-2024 | $0.4057 | $0.3944 | $0.42 | $0.39 | 37,420 | 10,547 | 28.19% |
06-27-2024 | $0.409 | $0.4 | $0.4099 | $0.39 | 26,787 | 12,198 | 45.54% |
06-26-2024 | $0.41 | $0.386 | $0.41 | $0.3821 | 29,547 | 8,218 | 27.81% |
06-25-2024 | $0.39 | $0.3819 | $0.4099 | $0.3819 | 24,728 | 5,952 | 24.07% |
06-24-2024 | $0.414 | $0.3895 | $0.42 | $0.3691 | 133,338 | 32,526 | 24.39% |
06-21-2024 | $0.424 | $0.42 | $0.424 | $0.3888 | 43,940 | 5,551 | 12.63% |
06-20-2024 | $0.4189 | $0.399 | $0.4299 | $0.398 | 116,573 | 35,837 | 30.74% |
06-18-2024 | $0.4 | $0.399 | $0.4263 | $0.38 | 173,356 | 33,750 | 19.47% |
06-17-2024 | $0.4464 | $0.399967 | $0.46 | $0.39 | 153,849 | 45,500 | 29.57% |
06-14-2024 | $0.508 | $0.4545 | $0.5088 | $0.4411 | 164,490 | 40,489 | 24.61% |
06-13-2024 | $0.536 | $0.5669 | $0.5669 | $0.48755 | 737,277 | 44,772 | 6.07% |
06-12-2024 | $0.543 | $0.49 | $0.5499 | $0.4636 | 100,822 | 15,284 | 15.16% |
06-11-2024 | $0.5622 | $0.54 | $0.5626 | $0.5069 | 13,998 | 4,330 | 30.93% |
06-10-2024 | $0.577 | $0.56 | $0.578 | $0.5581 | 31,712 | 5,747 | 18.12% |
06-07-2024 | $0.5562 | $0.58 | $0.5869 | $0.5562 | 8,443 | 4,884 | 57.85% |
06-06-2024 | $0.58 | $0.58 | $0.6 | $0.554 | 51,198 | 22,746 | 44.43% |
News, Short Squeeze, Breakout and More Instantly...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...
Investor had agreed to purchase up to $25 million of preferred shares Alzamend expects to use proceeds to further its clinical trials and working capital purposes Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical compa...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...